Rigel Pharmaceuticals, Inc. (RIGL) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Rigel Pharmaceuticals (RIGL) Q1 2026: 26% Product Sales Growth Anchors Pipeline and Portfolio Expansion
May 06, 2026
-
Rigel Pharmaceuticals (RIGL) Q4 2025: Net Product Sales Jump 60% as Portfolio Expansion Accelerates Cash Generation
March 04, 2026
-
Rigel Pharmaceuticals (RIGL) Q3 2025: Net Product Sales Jump 65% as Pipeline and Global Expansion Accelerate
November 05, 2025
-
Rigel Pharmaceuticals (RIGL) Q2 2025: Net Product Sales Up 76% as IRA Affordability Drives Portfolio Acceleration
August 06, 2025
-
Rigel Pharmaceuticals (RIGL) Q1 2025: Net Income Turns Positive on 68% Product Sales Surge
July 07, 2025